PCVX Vaxcyte Inc
503
$74.57
$0.88
(1.17%)
| Watchers | 503 |
| 52-Wk Low | $44.20 |
| 52-Wk High | $82.04 |
| Market Cap | $8.11B |
| Volume | 688,017.00 |
| 52-Wk High | $82.04 |
| 52-Wk Low | $44.20 |
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare ConferenceGlobe Newswire • about 2 months ago
SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Share to Feed
For the last three days, A.I.dvisor has detected that PCVX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Shares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) have received an average recommendation of "Buy" from the five brokerages that are currently covering the stock, Marketbeat.com reports. Five...
For the last three days, A.I.dvisor has detected that PCVX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
For the last three days, A.I.dvisor has detected that PCVX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Related Stocks: PCVX...
Citigroup Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX Free Report) by 21.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The...
Wellington Management Group LLP grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX Free Report) by 3.8% during the third quarter, according to its most recent 13F filing with the SEC...
Vaxcyte, Inc. (NASDAQ:PCVX Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 29th, there was short interest totalling...
Shares of Vaxcyte, Inc. (NASDAQ:PCVX Get Free Report) have received an average recommendation of Buy from the five ratings firms that are currently covering the stock...